Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of XORTX Therapeutics (NASDAQ:XRTX) through any online brokerage.
Other companies in XORTX Therapeutics’s space includes: 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP), Kiora Pharmaceuticals Inc (NASDAQ:KPRX), SciSparc Ltd (NASDAQ:SPRC), InMed Pharmaceuticals Inc (NASDAQ:INM) and Akanda Corp (NASDAQ:AKAN).
XORTX Therapeutics has a consensus price target of $14.00.
The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $0.6 last updated December 16, 2025 at 10:22 AM EST.
There are no upcoming dividends for XORTX Therapeutics.
XORTX Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for XORTX Therapeutics.
XORTX Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.